Trump Administration Partially Reschedules Cannabis, Causing Confusion

The Trump administration partially reschedules cannabis, moving state medical cannabis and FDA-approved products from schedule I to schedule III. This change, signed by acting attorney general Todd Blanche, creates confusion within the cannabis industry, as experts note it complicates an already complex regulatory process.

Read the full story at The Guardian AU→